Perspectives on the development and future of oocyte IVM in clinical practice

Oocyte in vitro maturation (IVM) is an assisted reproductive technology designed to obtain mature oocytes following culture of immature cumulus–oocyte complexes collected from antral follicles. Although IVM has been practiced for decades and is no longer considered experimental, the uptake of IVM in...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vos, Michel, Grynberg, Michaël, Ho, Tuong M., Yuan, Ye, Albertini, David F., Gilchrist, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266966/
https://www.ncbi.nlm.nih.gov/pubmed/34218388
http://dx.doi.org/10.1007/s10815-021-02263-5
_version_ 1783720042382229504
author De Vos, Michel
Grynberg, Michaël
Ho, Tuong M.
Yuan, Ye
Albertini, David F.
Gilchrist, Robert B.
author_facet De Vos, Michel
Grynberg, Michaël
Ho, Tuong M.
Yuan, Ye
Albertini, David F.
Gilchrist, Robert B.
author_sort De Vos, Michel
collection PubMed
description Oocyte in vitro maturation (IVM) is an assisted reproductive technology designed to obtain mature oocytes following culture of immature cumulus–oocyte complexes collected from antral follicles. Although IVM has been practiced for decades and is no longer considered experimental, the uptake of IVM in clinical practice is currently limited. The purpose of this review is to ensure reproductive medicine professionals understand the appropriate use of IVM drawn from the best available evidence supporting its clinical potential and safety in selected patient groups. This group of scientists and fertility specialists, with expertise in IVM in the ART laboratory and/or clinic, explore here the development of IVM towards acquisition of a non-experimental status and, in addition, critically appraise the current and future role of IVM in human ART.
format Online
Article
Text
id pubmed-8266966
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82669662021-07-20 Perspectives on the development and future of oocyte IVM in clinical practice De Vos, Michel Grynberg, Michaël Ho, Tuong M. Yuan, Ye Albertini, David F. Gilchrist, Robert B. J Assist Reprod Genet Commentary Oocyte in vitro maturation (IVM) is an assisted reproductive technology designed to obtain mature oocytes following culture of immature cumulus–oocyte complexes collected from antral follicles. Although IVM has been practiced for decades and is no longer considered experimental, the uptake of IVM in clinical practice is currently limited. The purpose of this review is to ensure reproductive medicine professionals understand the appropriate use of IVM drawn from the best available evidence supporting its clinical potential and safety in selected patient groups. This group of scientists and fertility specialists, with expertise in IVM in the ART laboratory and/or clinic, explore here the development of IVM towards acquisition of a non-experimental status and, in addition, critically appraise the current and future role of IVM in human ART. Springer US 2021-07-03 2021-06 /pmc/articles/PMC8266966/ /pubmed/34218388 http://dx.doi.org/10.1007/s10815-021-02263-5 Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
De Vos, Michel
Grynberg, Michaël
Ho, Tuong M.
Yuan, Ye
Albertini, David F.
Gilchrist, Robert B.
Perspectives on the development and future of oocyte IVM in clinical practice
title Perspectives on the development and future of oocyte IVM in clinical practice
title_full Perspectives on the development and future of oocyte IVM in clinical practice
title_fullStr Perspectives on the development and future of oocyte IVM in clinical practice
title_full_unstemmed Perspectives on the development and future of oocyte IVM in clinical practice
title_short Perspectives on the development and future of oocyte IVM in clinical practice
title_sort perspectives on the development and future of oocyte ivm in clinical practice
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266966/
https://www.ncbi.nlm.nih.gov/pubmed/34218388
http://dx.doi.org/10.1007/s10815-021-02263-5
work_keys_str_mv AT devosmichel perspectivesonthedevelopmentandfutureofoocyteivminclinicalpractice
AT grynbergmichael perspectivesonthedevelopmentandfutureofoocyteivminclinicalpractice
AT hotuongm perspectivesonthedevelopmentandfutureofoocyteivminclinicalpractice
AT yuanye perspectivesonthedevelopmentandfutureofoocyteivminclinicalpractice
AT albertinidavidf perspectivesonthedevelopmentandfutureofoocyteivminclinicalpractice
AT gilchristrobertb perspectivesonthedevelopmentandfutureofoocyteivminclinicalpractice

Ejemplares similares